Univariable | Multivariable | |||||
OR | 95% CI | P value | OR | 95% CI | P value | |
Age | 0.988 | 0.978 to 0.999 | 0.028 | 0.974 | 0.953 to 0.995 | 0.016 |
Male gender | 1.610 | 1.157 to 2.242 | 0.005 | 0.998 | 0.505 to 1.971 | 0.995 |
Body mass index | 0.948 | 0.909 to 0.988 | 0.012 | 0.933 | 0.865 to 1.007 | 0.073 |
Systolic blood pressure | 0.999 | 0.994 to 1.004 | 0.666 | |||
Heart rate | 1.016 | 1.010 to 1.022 | <0.001 | 1.012 | 0.996 to 1.029 | 0.138 |
NYHA class III or IV | 1.212 | 0.521 to 2.819 | 0.655 | |||
Coronary artery disease | 2.079 | 1.499 to 2.885 | <0.001 | 2.112 | 1.047 to 4.259 | 0.037 |
Atrial fibrillation | 1.317 | 0.958 to 1.809 | 0.090 | |||
Hypertension | 1.391 | 0.968 to 1.997 | 0.074 | |||
Diabetes | 1.609 | 1.168 to 2.217 | 0.004 | 1.517 | 0.789 to 2.915 | 0.211 |
Dyslipidaemia | 1.048 | 0.739 to 1.489 | 0.795 | |||
Chronic kidney disease | 1.514 | 1.099 to 2.084 | 0.011 | 0.694 | 0.342 to 1.409 | 0.312 |
Anaemia | 1.700 | 1.225 to 2.360 | 0.001 | 1.378 | 0.699 to 2.719 | 0.355 |
Hyperuricaemia | 2.432 | 1.717 to 3.443 | <0.001 | 1.372 | 0.681 to 2.762 | 0.376 |
Sleep-disordered breathing | 2.099 | 1.526 to 2.888 | <0.001 | 1.212 | 1.007 to 1.472 | 0.042 |
COPD | 1.265 | 0.885 to 1.810 | 0.197 | |||
Peripheral artery disease | 1.606 | 0.993 to 2.596 | 0.093 | |||
Smoking | 0.948 | 0.691 to 1.302 | 0.743 | |||
Alcohol | 0.648 | 0.346 to 1.212 | 0.175 | |||
Log BNP | 2.600 | 1.864 to 3.628 | <0.001 | 1.543 | 0.845 to 2.817 | 0.158 |
Log troponin I | 1.465 | 1.222 to 1.756 | <0.001 | 1.574 | 1.055 to 2.349 | 0.026 |
LVDd | 1.080 | 1.059 to 1.101 | <0.001 | 1.069 | 1.030 to 1.109 | <0.001 |
LVEF | 0.908 | 0.888 to 0.927 | <0.001 | 0.933 | 0.902 to 0.966 | <0.001 |
CLBBB | 2.791 | 0.809 to 9.634 | 0.104 | |||
QRS | 1.008 | 1.001 to 1.015 | 0.026 | 0.997 | 0.983 to 1.011 | 0.662 |
QT | 0.999 | 0.995 to 1.003 | 0.559 | |||
QTc | 1.008 | 1.003 to 1.012 | 0.002 | 1.004 | 0.995 to 1.013 | 0.409 |
RAS inhibitors | 0.725 | 0.547 to 0.936 | 0.037 | 0.931 | 0.472 to 1.388 | 0.281 |
Mineral receptor antagonist | 0.926 | 0.562 to 1.324 | 0.463 | |||
Calcium channel blocker | 0.893 | 0.647 to 1.234 | 0.494 | |||
Beta blocker | 0.892 | 0.413 to 1.326 | 0.782 | |||
Diuretic | 2.879 | 1.975 to 4.197 | <0.001 | 2.272 | 0.970 to 5.320 | 0.414 |
Statin | 1.297 | 0.943 to 1.783 | 0.110 | |||
Digitalis | 1.501 | 0.915 to 2.462 | 0.108 | |||
ICD | 1.180 | 0.744 to 1.871 | 0.482 |
BNP, B-type natriuretic peptide; CLBBB, complete left bundle branch block; COPD, chronic obstructive pulmonary disease; HFpEF, heart failure with preserved LVEF; ICD, implantable cardiac defibrillator; LVDd, left ventricular end diastolic dimension; LVEF, left ventricular ejection fraction; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; RAS, renin–angiotensin–aldosterone system; rEF, reduced LVEF at second assessment.